Orchestra BioMed Holdings, Inc. Basic Shares Outstanding (Weighted Average)
Orchestra BioMed Holdings, Inc. (OBIO) reported Basic Shares Outstanding (Weighted Average) of 63.81 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 63.81M shares, a 66.21% increase year-over-year.
- Orchestra BioMed Holdings, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 62.72M shares, a 64.04% increase year-over-year.
- Orchestra BioMed Holdings, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 61.97M shares, a 62.80% increase year-over-year.
- Orchestra BioMed Holdings, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 52.19M shares, a 38.71% increase year-over-year.
- Orchestra BioMed Holdings, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 47.75M shares, a 29.67% increase from fiscal 2024.
- Orchestra BioMed Holdings, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 36.82M shares, a 10.82% increase from fiscal 2023.
- Orchestra BioMed Holdings, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 33.23M shares, a 121.67% increase from fiscal 2022.
- Orchestra BioMed Holdings, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 14.99M shares, a 26.71% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 63.81M shares 10-Q · filed 2026-08-10 | 62.02M shares 10-Q · filed 2026-08-10 | 62.83M shares derived: average of 3 quarters · filed 2026-08-10 | 60.17M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | 62.72M shares 10-Q · filed 2026-05-12 | 62.34M shares derived: average of 2 quarters · filed 2026-05-12 | 58.96M shares derived: average of 3 quarters · filed 2026-05-12 | 53.82M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | 61.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 57.08M shares derived: average of 2 quarters · filed 2026-03-12 | 50.85M shares derived: average of 3 quarters · filed 2026-08-10 | 47.75M shares 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | 52.19M shares 10-Q · filed 2025-11-10 | 45.29M shares derived: average of 2 quarters · filed 2026-08-10 | 43.01M shares 10-Q · filed 2025-11-10 | 41.72M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | 38.39M shares 10-Q · filed 2026-08-10 | 38.31M shares 10-Q · filed 2026-08-10 | 38.23M shares derived: average of 3 quarters · filed 2026-08-10 | 38.08M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | 38.24M shares 10-Q · filed 2026-05-12 | 38.15M shares derived: average of 2 quarters · filed 2026-05-12 | 37.97M shares derived: average of 3 quarters · filed 2026-05-12 | 37.43M shares derived: average of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | 38.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 37.84M shares derived: average of 2 quarters · filed 2026-03-12 | 37.16M shares derived: average of 3 quarters · filed 2026-03-12 | 36.82M shares 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | 37.62M shares 10-Q · filed 2025-11-10 | 36.71M shares derived: average of 2 quarters · filed 2025-11-10 | 36.41M shares 10-Q · filed 2025-11-10 | 36.09M shares derived: average of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | 35.80M shares 10-Q · filed 2025-08-12 | 35.79M shares 10-Q · filed 2025-08-12 | 35.57M shares derived: average of 3 quarters · filed 2025-08-12 | 35.49M shares derived: average of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | 35.78M shares 10-Q · filed 2025-05-12 | 35.46M shares derived: average of 2 quarters · filed 2025-05-12 | 35.39M shares derived: average of 3 quarters · filed 2025-05-12 | 35.19M shares derived: average of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | 35.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 35.19M shares derived: average of 2 quarters · filed 2025-03-31 | 35.00M shares derived: average of 3 quarters · filed 2025-03-31 | 33.23M shares 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | 35.24M shares 10-Q · filed 2024-11-12 | 34.93M shares derived: average of 2 quarters · filed 2024-11-12 | 32.59M shares 10-Q · filed 2024-11-12 | 29.44M shares derived: average of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | 34.61M shares 10-Q · filed 2024-08-12 | 31.23M shares 10-Q · filed 2024-08-12 | 27.50M shares derived: average of 3 quarters · filed 2024-08-12 | 25.67M shares derived: average of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | 27.64M shares 10-Q · filed 2024-05-13 | 23.94M shares derived: average of 2 quarters · filed 2024-05-13 | 22.69M shares derived: average of 3 quarters · filed 2024-05-13 | 19.55M shares derived: average of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | 20.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | 20.22M shares derived: average of 2 quarters · filed 2024-03-27 | 16.86M shares derived: average of 3 quarters · filed 2024-03-27 | 14.99M shares 10-K · filed 2024-03-27 | 16.43M shares 10-K · filed 2023-01-25 | |||
| 2022-09-30 | 20.19M shares 10-Q · filed 2023-11-13 | 13.72M shares 10-Q · filed 2022-11-14 | 15.16M shares derived: average of 2 quarters · filed 2023-11-13 | 13.24M shares 10-Q · filed 2023-11-13 | 18.18M shares 10-Q · filed 2022-11-14 | 15.00M shares derived: average of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | 10.14M shares 10-Q · filed 2023-08-10 | 20.45M shares 10-Q · filed 2022-08-15 | 18.45M shares 10-Q · filed 2023-08-10 | 20.45M shares 10-Q · filed 2022-08-15 | 13.27M shares derived: average of 3 quarters · filed 2023-08-10 | 15.07M shares derived: average of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | 9.23M shares 10-Q · filed 2023-05-12 | 20.45M shares 10-Q · filed 2022-05-13 | 14.84M shares derived: average of 2 quarters · filed 2023-05-12 | 16.71M shares derived: average of 3 quarters · filed 2023-05-12 | 17.64M shares derived: average of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | 20.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-25 | 20.45M shares derived: average of 2 quarters · filed 2023-01-25 | 20.45M shares derived: average of 3 quarters · filed 2023-01-25 | 20.45M shares 10-K · filed 2023-01-25 | ||||
| 2021-09-30 | 20.45M shares 10-Q · filed 2022-11-14 | 20.45M shares derived: average of 2 quarters · filed 2022-11-14 | 20.45M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 20.45M shares 10-Q · filed 2022-08-15 | 20.45M shares 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | 20.45M shares 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |